(Q33694958)

28 July 2017

1 reference

title

Progestins in the menopause (English)

1 reference

28 July 2017

Sitruk-Ware R

1

1 reference

28 July 2017

publication date

1 April 1999

1 reference

The Journal of Steroid Biochemistry and Molecular Biology

28 July 2017

published in

1 reference

28 July 2017

volume

69

1 reference

28 July 2017

issue

1-6

1 reference

28 July 2017

page(s)

185-193

1 reference

Hormone replacement therapy and endometrial cancer risk: a meta-analysis

28 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900053-9

7 January 2021

Incidence of endometrial hyperplasia in postmenopausal women taking conjugated estrogens (Premarin) with medroxyprogesterone acetate or conjugated estrogens alone. The Menopause Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900053-9

7 January 2021

Estrone sulfate-sulfatase and 17 beta-hydroxysteroid dehydrogenase activities: a hypothesis for their role in the evolution of human breast cancer from hormone-dependence to hormone-independence

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900053-9

7 January 2021

Progestin regulation of cellular proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900053-9

7 January 2021

Nomegestrol acetate, a clinically useful 19-norprogesterone derivative which lacks estrogenic activity

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900053-9

7 January 2021

Progestogen use and decreased risk of breast cancer in a cohort study of premenopausal women with benign breast disease

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900053-9

7 January 2021

Aspects of progestin activity on the breast. European Progestin Club

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900053-9

7 January 2021

Increased risk of atherosclerosis in women after the menopause

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900053-9

7 January 2021

Hormone therapy to prevent disease and prolong life in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900053-9

7 January 2021

Hormone replacement therapy and cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900053-9

7 January 2021

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900053-9

7 January 2021

Acute effect of oestrogen replacement therapy on treadmill performance in postmenopausal women with coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900053-9

7 January 2021

Insulin resistance, secretion, and elimination in postmenopausal women receiving oral or transdermal hormone replacement therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900053-9

7 January 2021

Transdermal estrogen replacement therapy: beneficial effects on hemostatic risk factors for cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900053-9

7 January 2021

Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900053-9

7 January 2021

Inhibition of coronary artery atherosclerosis by 17-beta estradiol in ovariectomized monkeys. Lack of an effect of added progesterone

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900053-9

7 January 2021

Serum High-Density-Lipoprotein Cholesterol in Women Using Oral Contraceptives, Estrogens and Progestins

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900053-9

7 January 2021

Postmenopausal Estrogen and Progestin Use and the Risk of Cardiovascular Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900053-9

7 January 2021

The risk of myocardial infarction associated with the combined use of estrogens and progestins in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900053-9

7 January 2021

Estrogen modulates responses of atherosclerotic coronary arteries

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900053-9

7 January 2021

Comparison of transdermal and oral estrogen-progestin replacement therapy: effects on serum lipids and lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900053-9

7 January 2021

Cardiovascular risk factors and combined estrogen-progestin replacement therapy: a placebo-controlled study with nomegestrol acetate and estradiol

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900053-9

7 January 2021

Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900053-9

7 January 2021

Insulin receptors during the menstrual cycle in normal women

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900053-9

7 January 2021

Effect of insulin on the proliferation of cultured primate arterial smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900053-9

7 January 2021

Low-density lipoprotein receptor activity in cultured human skin fibroblasts. Mechanism of insulin-induced stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900053-9

7 January 2021

Carbohydrate metabolism during hormonal substitution therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900053-9

7 January 2021

Effects of nomegestrol acetate (5 mg/d) on hormonal, metabolic and hemostatic parameters in premenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900053-9

7 January 2021

Lack of influence of menopause on blood pressure and cardiovascular risk profile: a 16-year longitudinal study concerning a cohort of 568 women.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900053-9

7 January 2021

Estrogen and progesterone receptors in vessel walls. Biochemical and immunochemical assays

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900053-9

7 January 2021

Basal release of nitric oxide from aortic rings is greater in female rabbits than in male rabbits: implications for atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900053-9

7 January 2021

The long-term effects of oral and transdermal postmenopausal hormone replacement therapy on nitric oxide, endothelin-1, prostacyclin, and thromboxane

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900053-9

7 January 2021

Estrogen and progesterone inhibit vascular smooth muscle proliferation.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900053-9

7 January 2021

Progesterone inhibits arterial smooth muscle cell proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900053-9

7 January 2021

Endothelial-dependent coronary vasomotor responsiveness in postmenopausal women with and without estrogen replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900053-9

7 January 2021

Beneficial effect of oestrogen on exercise-induced myocardial ischaemia in women with coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900053-9

7 January 2021

17 beta-Estradiol attenuates acetylcholine-induced coronary arterial constriction in women but not men with coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900053-9

7 January 2021

Effects of hormone replacement therapy on reactivity of atherosclerotic coronary arteries in cynomolgus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900053-9

7 January 2021

Medroxyprogesterone interferes with ovarian steroid protection against coronary vasospasm

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900053-9

7 January 2021

Estrogens, progestins and coronary artery reactivity

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900053-9

7 January 2021

Estrogens, progestins, and coronary artery reactivity in atherosclerotic monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900053-9

7 January 2021

10.1016/S0960-0760(99)00053-9

Identifiers

DOI

1 reference

28 July 2017

1 reference